Net Income (TTM) Chart

Historical Net Income (TTM) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -13.03M
March 31, 2026 -41.08M
December 31, 2025 -38.99M
September 30, 2025 -36.52M
June 30, 2025 -42.01M
March 31, 2025 -18.64M
December 31, 2024 -24.20M
September 30, 2024 -32.86M
June 30, 2024 -35.47M
March 31, 2024 -33.42M
December 31, 2023 -34.31M
September 30, 2023 -42.64M
June 30, 2023 -39.49M
March 31, 2023 -37.59M
December 31, 2022 -39.30M
September 30, 2022 -39.86M
Date Value
June 30, 2022 -45.62M
March 31, 2022 -53.45M
December 31, 2021 -55.64M
September 30, 2021 -53.44M
June 30, 2021 -53.20M
March 31, 2021 -48.01M
December 31, 2020 -39.62M
September 30, 2020 -33.35M
June 30, 2020 -27.29M
March 31, 2020 -25.51M
December 31, 2019 -27.42M
September 30, 2019 -22.15M
June 30, 2019 -20.65M
March 31, 2019 -16.69M
December 31, 2018 -18.62M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (TTM) Range, Past 5 Years

View Net Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (TTM) Benchmarks

View Net Income (TTM) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc -5.93M
Mereo BioPharma Group Plc -28.05M
BioNTech SE -1.965B
Silence Therapeutics Plc -59.95M
Compass Pathways Plc -407.35M